Stock Analysis
- United States
- /
- Medical Equipment
- /
- NYSE:TFX
Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?
Today we're going to take a look at the well-established Teleflex Incorporated (NYSE:TFX). The company's stock saw a decent share price growth in the teens level on the NYSE over the last few months. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Teleflex’s outlook and value based on the most recent financial data to see if the opportunity still exists.
View our latest analysis for Teleflex
What is Teleflex worth?
Good news, investors! Teleflex is still a bargain right now. According to my valuation, the intrinsic value for the stock is $440.72, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. However, given that Teleflex’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.
What does the future of Teleflex look like?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 38% over the next couple of years, the future seems bright for Teleflex. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
What this means for you:
Are you a shareholder? Since TFX is currently undervalued, it may be a great time to increase your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.
Are you a potential investor? If you’ve been keeping an eye on TFX for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy TFX. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.
If you'd like to know more about Teleflex as a business, it's important to be aware of any risks it's facing. At Simply Wall St, we found 1 warning sign for Teleflex and we think they deserve your attention.
If you are no longer interested in Teleflex, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
What are the risks and opportunities for Teleflex?
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
Rewards
Trading at 24.9% below our estimate of its fair value
Earnings are forecast to grow 13.5% per year
Risks
No risks detected for TFX from our risks checks.
Further research on
Teleflex
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.